SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Originally established in Punjab, the Vasculitis Society of India is now expanding its footprint nationwide
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
Subscribe To Our Newsletter & Stay Updated
